Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOBE-SMART: Oral enzyme treatment (Wobenzym) in knee osteoarthritis
2020-003154-80Phase 4Completed
- Sponsor
- Mucos Pharma
- Start
- Oct 2020
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of trypsin + bromelain + rutoside in osteoarthritis (OA) (2 arms), sponsored by Mucos Pharma. Primary endpoint: Primary pharmacodynamic endpoints. Started Oct 2020; status: completed.
02
Drugs
trypsin + bromelain + rutoside
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2020-003154-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003154-80.